Lion Biotechnologies to Participate in Upcoming Conferences
NEW YORK, NY--(Marketwired - March 07, 2016) - Lion Biotechnologies, (NASDAQ: LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced that President and Chief Executive …